Ido Yofe (@idoyofe) 's Twitter Profile
Ido Yofe

@idoyofe

Principal Investigator | Metastasis Genomics Research Group | Sheba Medical Center, Israel.

ID: 1060736547379732482

calendar_today09-11-2018 03:31:15

1,1K Tweet

220 Followers

628 Following

Shai (@shaifoon) 's Twitter Profile Photo

עידו הוא מדען בחסד ואדם נדיר לעבוד איתו. הזדמנות פנטסטית להצטרף למעבדה בהקמה שתניב תובנות פורצות דרך בהבנת מחלות גרורתיות.

Fadi Sheban (@fadisheban) 's Twitter Profile Photo

Exciting news! Incredible opportunity for cutting-edge metastasis research with my brilliant former colleague Ido Yofe - an exceptional scientist and wonderful person. 🚀

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Because ONE spatial profiling technology is not enough! New paper by Nikhil Wagle, MD (he/him) in Nature Medicine A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features nature.com/articles/s4159… Dissociated single

Because ONE spatial profiling technology is not enough!
New paper by <a href="/Nikhilwagle/">Nikhil Wagle, MD (he/him)</a> in <a href="/NatureMedicine/">Nature Medicine</a> 
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features
nature.com/articles/s4159…
Dissociated single
Karuna Ganesh (@karunamdphd) 's Twitter Profile Photo

Thrilled to share our paper now out nature delineating #plasticity during #CRC #metastasis, a fantastic collaboration led by Andrew Moorman Ellie Benitez, and @f_cambuli from the Karuna Ganesh Lab and @dana_per lab! nature.com/articles/s4158… rdcu.be/dYAVK. A 🧵

Thrilled to share our paper now out <a href="/Nature/">nature</a> delineating #plasticity during #CRC #metastasis, a fantastic collaboration led by <a href="/andrewrmoorman/">Andrew Moorman</a> <a href="/elliebenitez11/">Ellie Benitez</a>, and @f_cambuli from the <a href="/KarunaGaneshLab/">Karuna Ganesh Lab</a> and @dana_per lab! nature.com/articles/s4158…
rdcu.be/dYAVK.  A 🧵
Leeat Keren (@leeat_keren) 's Twitter Profile Photo

Preprint alert! We profiled immune organization in sentinel lymph nodes (sLNs) of melanoma patients using spatial proteomics and spatial transcriptomics, and found that it is prognostic of distant metastases: biorxiv.org/cgi/content/sh…

Wenbin Mei (@wenbin_mei) 's Twitter Profile Photo

EXCITED to share my PhD work in Cell. We found that the chance of developing metastasis is partly decided by the DNA we inherited. We identified a germline variant in PCSK9 present in 70% of the white women conferring higher risk of breast cancer metastasis. (1/9)

EXCITED to share my PhD work in <a href="/CellCellPress/">Cell</a>. We found that the chance of developing metastasis is partly decided by the DNA we inherited. We identified a germline variant in PCSK9 present in 70% of the white women conferring higher risk of breast cancer metastasis. (1/9)
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Update: ✅ 5 of the highly awaited BC trials with positive results ❌ one negative trial (but with positive OS) Results from the remaining trials expected in 2025. Breast oncology keeps moving extremely fast.

Update:

✅ 5 of the highly awaited BC trials with positive results

❌ one negative trial (but with positive OS)

Results from the remaining trials expected in 2025.

Breast oncology keeps moving extremely fast.
Metastasis Research Society (@metastasisrs) 's Twitter Profile Photo

1/2024 was a big year for metastasis research! Check out our top articles on metastasis research from this year below. The field is driving progress and promise for patients with metastatic cancer. Join MRS for monthly updates on all things metastasis: metastasis-research.org/for-researcher…

Metastasis Research Society (@metastasisrs) 's Twitter Profile Photo

7/Uncover the immune landscape of metastatic niches. This study maps single-cell profiles, identifying TREM2+ regulatory macrophages at invasive margins as drivers of immune evasion. Ido Yofe IdoAmitLab pubmed.ncbi.nlm.nih.gov/37756565/

Cancer Discovery (@cd_aacr) 's Twitter Profile Photo

Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary brnw.ch/21wQWsx By corresponding author and #AACRIO25 speaker Ido Amit IdoAmitLab

Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary brnw.ch/21wQWsx

By corresponding author and #AACRIO25 speaker Ido Amit <a href="/IdoAmitLab/">IdoAmitLab</a>
המרכז הרפואי שיבא (@sheba_) 's Twitter Profile Photo

גאווה ישראלית: שיבא מטפס למקום ה-8 בעולם! המרכז הרפואי שיבא ממשיך להוביל ומטפס למקום ה-8 בדירוג בתי החולים הטובים בעולם של Newsweek – הישג בינלאומי יוצא דופן למערכת הבריאות הישראלית. השנה האחרונה הציבה אתגר עצום, ושיבא היה בלב המענה הרפואי:

Ido Yofe (@idoyofe) 's Twitter Profile Photo

The Yofe Lab at Sheba is looking for scientists: 🥼Research Associate • PhD & MSc students 🎓 Our new cancer research group is focused on studying metastasis with cutting-edge tech. Interested? Send your CV & cover letter to: [email protected]

The Yofe Lab at Sheba is looking for scientists: 
🥼Research Associate • PhD &amp; MSc students 🎓

Our new cancer research group is focused on studying metastasis with cutting-edge tech.

Interested? Send your CV &amp; cover letter to: 
Join.Yofe.Lab@gmail.com
Merav Cohen Lab (@mcohenlab) 's Twitter Profile Photo

We are beyond excited to share the first publication of our lab! We highlight the role of #neutrophils in shaping a more aggressive #TME through physical interactions with #breastcancer cells. The work was led by the talented Sandra Camargo 🎗️💔 & Ori Moskowitz 🧵nature.com/articles/s4301…

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

The curves everybody’s been waiting for. First line T-DXd + pertuzumab significantly prolonged PFS over THP for HER2+ MBC (40.7 vs 26.9 months, HR 0.56, p<0.001), doubled the rate of complete responses (15% vs 8%) and had a positive OS trend (HR 0.84). Practice changing data.

The curves everybody’s been waiting for. 

First line T-DXd + pertuzumab significantly prolonged PFS over THP for HER2+ MBC (40.7 vs 26.9 months, HR 0.56, p&lt;0.001), doubled the rate of complete responses (15% vs 8%) and had a positive OS trend (HR 0.84). Practice changing data.